Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending April 30, 2012. The report details a share repurchase transaction executed in accordance with shareholder authority granted at the Annual General Meeting on May 5, 2011.
Key Financial Metrics
The filing does not provide data on revenue, profit, cash flow, margins, debt, or liquidity. It focuses exclusively on capital structure changes related to share buybacks.
- Shares Purchased: 950,000 Ordinary shares of 25 pence each.
- Purchase Date: April 30, 2012.
- Price Range: Highest price paid was 1,436 pence per share; lowest price paid was 1,426 pence per share.
- Treasury Holdings (Settled): 517,042,927 shares (9.29% of total issued share capital).
- Treasury Holdings (Including Unsettled): 519,192,927 shares (10.29% of total voting rights).
- Shares in Issue (Excluding Treasury): 5,046,641,394 shares.
Material Changes
The primary material change is the reduction of outstanding shares through the purchase of 950,000 shares, increasing the proportion of shares held in Treasury. The filing does not provide comparative financial data to assess changes in operating performance versus prior periods.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or outlook. It includes a standard disclaimer stating the announcement does not constitute an offer or solicitation to purchase securities and confirms conformity with the Financial Services Authority's Disclosure and Transparency Rules.
Investor Verification Checklist
- Verify the total number of shares held in Treasury (517,042,927 settled) against the company's latest capitalization table.
- Confirm the calculation of total voting rights (10.29% held in Treasury including unsettled shares).
- Check the remaining authorized share buyback limit under the authority granted on May 5, 2011.
- Review the settlement status of the 1,150,000 shares purchased but not yet settled (difference between settled and total treasury holdings).